Abstract
Low dose methotrexate (MTX) still remains as the cornerstone in the treatment of rheumatic diseases such as rheumatoid arthritis (RA) and psoriatic arthritis. Clinicians have been aware of common side effects of MTX for over five decades, whereas there have been rarely seen and relatively easily overlooked complications that had been reported to be associated with MTX in the literature, such as MTX osteopathy. The use of high doses of MTX has been demonstrated to have negative effects on bone formation and bone mineral density as well as long-term low dose, which is relatively less common. Diagnosis of MTX osteopathy might be challenging as there is no specific clinical features. Herein, we present 3 patients with RA diagnosis who developed MTX osteopathy during follow-ups.
Publisher
South Kazakhstan Medical Academy
Reference8 articles.
1. Torres RP, Santos FP, Branco JC. Methotrexate: implications of pharmacogenetics in the treatment of patients with rheumatoid arthritis. ARP Rheumatol 2022;1(3):225-229.
2. Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis 1993;52(8):582-585.
3. Robin F, Cadı S, Albert JD, Bart G, Coiffier G, Guggenbuhl P. Methotrexate osteopathy: five cases and systematic literature review. Osteoporos Int 2021;32(2):225-232.
4. Ruffer N, Krusche M, Beil FT, Amling M, Kötter I, Rolvien T. Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: a systematic review. Semin Arthritis Rheum 2022;52:151952.
5. di Munno O, Mazzantini M, Sinigaglia L, Bianchi G, Minisola G, Muratore M, et al. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study. J Rheumatol 2004;31:1305-1309.